REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 38
08/03/2016 12:10
- Part 38: For the preceding part double click ID:nRSH4027RK
unaware of and/or that are beyond our control.Any failure to successfully
implement our business strategy may frustrate the achievement of our
financial or other targets or expectations and, in turn, materially
damage our brand and materially adversely affect our business, financial
position or results of operations. Adverse impact of a sustained economic
downturnA variety of significant risks may arise from a sustained global
economic downturn including for example the economic slowdown in China,
our second largest market. Additional pressure from governments and other
healthcare payers on medicine prices and volumes of sales in response to
recessionary pressures on budgets may cause a slowdown or a decline in
growth in some markets. In some cases, those governments most severely
impacted by the economic downturn may seek alternative ways to settle
- More to follow, for following part double click ID:nRSH4027RMRecent news on AstraZeneca
See all newsREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementRCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement